Trials / Completed
CompletedNCT06950554
Validity and Reliablity of i-TUG Via EncephaLog
From Clinic to Smartphone: Evaluating the i-TUG for Balance and Fall Risk in Chronic Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Istanbul University - Cerrahpasa · Academic / Other
- Sex
- All
- Age
- 18 Days – 75 Days
- Healthy volunteers
- Not accepted
Summary
This study investigated the test-retest reliability and construct validity of the i-TUG, standard TUG, and Berg Balance Scale (BBS) using the EncephaLog smartphone application in individuals with chronic ischemic stroke. A total of 49 participants were assessed in two sessions to evaluate test-retest reliability. Construct validity was analyzed using Pearson correlation coefficients. Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC) values were also calculated.
Detailed description
The study was conducted with 37 individuals diagnosed with chronic ischemic stroke. Participants were assessed using the i-TUG, TUG, BBS, and additional postural sway parameters collected via EncephaLog. Two test sessions were conducted to assess test-retest reliability. Pearson correlation coefficients were used to evaluate construct validity, and the Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC) were also calculated. Inclusion Criteria: * voluntary participation, * a diagnosis of stroke, no involvement in any physiotherapy program for at least three months prior to the study, * age between 18 and 75 years, * the ability to walk independently Functional Ambulation Scale (FAS) score greater than 3, * the spasticity of the m. gastrocnemius was graded as 2 or less on the Modified Ashworth Scale (MAS). Exclusion Criteria: * severe visual or cognitive impairments, * severe cardiovascular disease, or musculoskeletal conditions or skin disorders that affected the lower extremities.
Conditions
Timeline
- Start date
- 2024-11-25
- Primary completion
- 2025-03-05
- Completion
- 2025-04-05
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06950554. Inclusion in this directory is not an endorsement.